Download video

Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design

2.7K views

CU Cancer Center

3 years ago

Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design

Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design

Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design
54:05
Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design
by CU Cancer Center
preclinical in vivo PK studies \& allometric scaling
5:01
preclinical in vivo PK studies \& allometric scaling
by Chem Help ASAP
Application Of In Vitro And In Vivo Adme Pk Expl Tox Assays To Support Lead And Candidate Selections
36:56
Application Of In Vitro And In Vivo Adme Pk Expl Tox Assays To Support Lead And Candidate Selections
by ChemPartner
Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)
22:37
Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)
by Eurofins Discovery
In vivo vs. in vitro drug development
1:34
In vivo vs. in vitro drug development
by Biotech Primer
Precision Dosing Using PBPK Modeling
40:57
Precision Dosing Using PBPK Modeling
by Certara
Interspecies Drug Dosing using PK Directed Methods
47:55
Interspecies Drug Dosing using PK Directed Methods
by CU Cancer Center
Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)
36:18
Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)
by ScitoVation1
Simcyp In Vitro Analysis (SIVA) Toolkit: Get the Most From Your In Vitro Data
53:31
Simcyp In Vitro Analysis (SIVA) Toolkit: Get the Most From Your In Vitro Data
by Certara
Webinar: In vivo pharmacokinetic experiments in preclinical drug development
53:56
Webinar: In vivo pharmacokinetic experiments in preclinical drug development
by Symeres
Compound Delivery, PK-PD, \& Validation Studies in Oncology Research
55:30
Compound Delivery, PK-PD, \& Validation Studies in Oncology Research
by InsideScientific
In vitro and in vivo abuse deterrence evaluation of generic opioids (30of39) Complex Generics 2018
30:26
In vitro and in vivo abuse deterrence evaluation of generic opioids (30of39) Complex Generics 2018
by U.S. Food and Drug Administration
Webinar: Data Analytics for in vivo PK and Pharmacology
49:27
Webinar: Data Analytics for in vivo PK and Pharmacology
by Instem Discovery
Quantitative and Systems Pharmacology Approaches for the Development of Oncology Drugs
49:35
Quantitative and Systems Pharmacology Approaches for the Development of Oncology Drugs
by Certara
Pharmacokinetics Absorption, Distribution, Metabolism, Excretion | Made Easy
0:53
Pharmacokinetics Absorption, Distribution, Metabolism, Excretion | Made Easy
by SimpleNursing
How to Define \& Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing
55:19
How to Define \& Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing
by Certara
In Vitro Studies for Alternative BE Approaches to Comparative Clinical Endpoint BE Studies
20:46
In Vitro Studies for Alternative BE Approaches to Comparative Clinical Endpoint BE Studies
by U.S. Food and Drug Administration
PBPK to Guide Study Design and Product Development for Generic Dermatological Products
19:56
PBPK to Guide Study Design and Product Development for Generic Dermatological Products
by U.S. Food and Drug Administration
The Potential of PK BE Studies in Detecting Regional Deposition with Orally Inhaled Drugs
18:08
The Potential of PK BE Studies in Detecting Regional Deposition with Orally Inhaled Drugs
by U.S. Food and Drug Administration
Models for antimicrobial R\&D: Development and use of in vivo models for infectious disease research
1:28:10
Models for antimicrobial R\&D: Development and use of in vivo models for infectious disease research
by GARDP